Trade Mark Journal No.2026/037 11 September 2026

UK00004438950 1 September 2026 (5)

EMV

International priority date claimed: 24 July 2026 (Ireland) (202601883)

Class 5: Pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for treatment of inflammatory and gastrointestinal diseases and disorders; pharmaceutical preparations for treatment of inflammatory bowel disease and ulcerative colitis.

Gilead Sciences Ireland UC

Representative: Gilead Sciences Europe Ltd